Explore our materials

Filters

Results (14744)

Slideset

HIV

International Workshop on HIV Pediatrics 2021

Optimizing Antiretroviral Treatment and Viral Suppression for Adolescents and Young People Living with HIV by Implementing Operation Triple Zero (OTZ) in Four States in Nigeria - Franklin Emerenini, Nigeria

Slideset

HIV

International Workshop on HIV Pediatrics 2021

Rapid Antiretroviral NNRTI-Based Initiation among Youth Living with HIV Outcomes in the National Aids Program in Thailand - Sirinya Teeraananchai, Thailand

Slideset

HIV

International Workshop on HIV Pediatrics 2021

A Costing Analysis of Index-Linked HIV Testing for Children and Adolescents in Zimbabwe - Arthi Vasantharoopan, United Kingdom

Slideset

HIV

International Workshop on HIV Pediatrics 2021

Estimated Prevalence of Prior HIV Diagnosis Among Children Living With HIV in Eswatini, Lesotho, Malawi, Tanzania, Zambia, and Zimbabwe in the Population HIV Incidence Assessments (PHIA) - Chloe A. Teasdale, United States

Slideset

HIV

International Workshop on HIV Pediatrics 2021

Risk Factors for Post-Discharge Mortality Following Hospitalization for Severe Acute Malnutrition in Zimbabwe and Zambia - Mutsa Bwakura-Dangarembizi, Zimbabwe

Slideset

HIV

International Workshop on HIV Pediatrics 2021

Co-Trimoxazole Prophylaxis for Children Born to Mothers With HIV: Predicted Impact of Different Strategies on Mortality Up To the Age of Two Years - Colette Smith, United Kingdom

Slideset

HIV

International Workshop on HIV Pediatrics 2021

Pediatric ARV Optimization in a Real-World Setting: Dolutegravir Transition in Mozambique - Michelle M. Gill, United States

Slideset

HIV

International Workshop on HIV Pediatrics 2021

There is No Substitute for Hard Work(Ing Dolutegravir): Outcomes of Single Drug Substitutions Among CALHIV Shifted to a Dolutegravir Antiretroviral Regimen in Mbeya and Mwanza, Tanzania - Jason Bacha, Tanzania

Slideset

HIV

International Workshop on HIV Pediatrics 2021

Growth of Children HIV-Exposed and Uninfected in The Context of Lifelong Maternal Antiretroviral Therapy in Malawi - Gabriela Toledo, United Kingdom

Slideset

HIV

International Workshop on HIV Pediatrics 2021

Increased Infectious-Cause Hospitalization Among Infants Who Are HIV-Exposed Uninfected Compared to HIV-Unexposed - Kim Anderson, South Africa

Slideset

HIV

International Workshop on HIV Pediatrics 2021

Determinants of HIV-Free Survival in the Era of Lifelong Universal Antiretroviral Therapy (ART): Pooled Analysis of PEAWIL and IMPROVE Studies, Lesotho - Appolinaire Tiam, United States

Slideset

HIV

International Workshop on HIV Pediatrics 2021

Key Clinical and Programmatic Outcomes of HIV-Exposed Infants in the International Epidemiology Databases to Evaluate AIDS Consortium - Andrew Edmonds, United States

Explore our materials

Your Selection Clear All

Topic

Material Type

Event

Optimizing Antiretroviral Treatment and Viral Suppression for Adolescents and Young People Living with HIV by Implementing Operation Triple Zero (OTZ) in Four States in Nigeria - Franklin Emerenini, Nigeria

Rapid Antiretroviral NNRTI-Based Initiation among Youth Living with HIV Outcomes in the National Aids Program in Thailand - Sirinya Teeraananchai, Thailand

A Costing Analysis of Index-Linked HIV Testing for Children and Adolescents in Zimbabwe - Arthi Vasantharoopan, United Kingdom

Estimated Prevalence of Prior HIV Diagnosis Among Children Living With HIV in Eswatini, Lesotho, Malawi, Tanzania, Zambia, and Zimbabwe in the Population HIV Incidence Assessments (PHIA) - Chloe A. Teasdale, United States

Risk Factors for Post-Discharge Mortality Following Hospitalization for Severe Acute Malnutrition in Zimbabwe and Zambia - Mutsa Bwakura-Dangarembizi, Zimbabwe

Co-Trimoxazole Prophylaxis for Children Born to Mothers With HIV: Predicted Impact of Different Strategies on Mortality Up To the Age of Two Years - Colette Smith, United Kingdom

Pediatric ARV Optimization in a Real-World Setting: Dolutegravir Transition in Mozambique - Michelle M. Gill, United States

There is No Substitute for Hard Work(Ing Dolutegravir): Outcomes of Single Drug Substitutions Among CALHIV Shifted to a Dolutegravir Antiretroviral Regimen in Mbeya and Mwanza, Tanzania - Jason Bacha, Tanzania

Growth of Children HIV-Exposed and Uninfected in The Context of Lifelong Maternal Antiretroviral Therapy in Malawi - Gabriela Toledo, United Kingdom

Increased Infectious-Cause Hospitalization Among Infants Who Are HIV-Exposed Uninfected Compared to HIV-Unexposed - Kim Anderson, South Africa

Determinants of HIV-Free Survival in the Era of Lifelong Universal Antiretroviral Therapy (ART): Pooled Analysis of PEAWIL and IMPROVE Studies, Lesotho - Appolinaire Tiam, United States

Key Clinical and Programmatic Outcomes of HIV-Exposed Infants in the International Epidemiology Databases to Evaluate AIDS Consortium - Andrew Edmonds, United States